Innovative Eyewear officer eyes sale of up to 16K shares

Innovative Eyewear Inc (LUCY) is the issuer for a notice of proposed sale of securities under Rule 144 filed for officer Gayle Oswald.

Rhea-AI Filing Summary

Innovative Eyewear Inc (LUCY) is the issuer for a notice of proposed sale of securities under Rule 144 filed for officer Gayle Oswald. The notice covers up to 16,233 shares of common stock to be sold through Raymond James & Associates, Inc., arising from an RSU grant. Shares outstanding were 6,403,728 common shares as of 08/19/2026; this is a baseline figure, not the amount being sold.

Key Figures

Shares proposed to be sold: 16,233 shares Aggregate market value of securities: $11,525.00 Shares outstanding: 6,403,728 shares +1 more

4 metrics

Shares proposed to be sold 16,233 shares Common stock covered by the Rule 144 notice for Gayle Oswald

Aggregate market value of securities $11,525.00 Aggregate market value for the 16,233 shares listed in the notice

Shares outstanding 6,403,728 shares Common shares of Innovative Eyewear Inc outstanding as of 08/19/2026

Planned sale date reference 08/19/2026 Date associated with the securities information and acquisition details

Key Terms

Rule 144, Form 144, RSU Grant, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU Grant financial

"Common | 08/19/2026 | RSU Grant | Issuer"

attorney-in-fact regulatory

"as attorney-in-fact for Oswald Gayle"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for Innovative Eyewear Inc (LUCY)?

The Form 144 notifies of a proposed sale of 16,233 shares of Innovative Eyewear Inc common stock by officer Gayle Oswald under Rule 144, with the shares to be sold through Raymond James & Associates, Inc..

How many Innovative Eyewear (LUCY) shares are proposed to be sold under this Form 144?

The notice covers up to 16,233 shares of Innovative Eyewear Inc common stock. These shares are linked to an RSU grant and are planned to be sold through Raymond James & Associates, Inc. as the broker.

Who is the selling security holder in this Innovative Eyewear (LUCY) Form 144?

The securities are for the account of Gayle Oswald, identified as an officer of Innovative Eyewear Inc. Raymond James & Associates, Inc. is listed as the broker, with a representative signing as attorney-in-fact on Oswald’s behalf.

What is the aggregate market value and outstanding shares for LUCY in this Form 144?

The filing lists an aggregate market value of $11,525.00 for the 16,233 shares covered and states that 6,403,728 common shares were outstanding as of 08/19/2026, providing context for the issuer’s total equity base.

What is the origin of the Innovative Eyewear (LUCY) shares being sold under this Form 144?

The securities to be sold are tied to an RSU grant from the issuer. The Form 144 indicates the acquisition method as “RSU Grant” and lists the consideration type as Cash in the securities-to-be-sold section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 03:15 PM EDT Accepted by SEC EDGAR 08/19/2026 - 03:15 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002042078
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Innovative Eyewear Inc
SEC File Number	001-41392
Address of Issuer	11900 BISCAYNE BLVD STE 630 MIAMI FLORIDA 33181
Phone	786-910-1898
Name of Person for Whose Account the Securities are To Be Sold	Gayle Oswald
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates,Inc. 880 Carillon Parkway St. Petersburg FL 33716	16233	11525.00	6403728	08/19/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2026	RSU Grant	Issuer			16233	08/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Melissa Fisher, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Oswald Gayle
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)